If approved, etrasimod will also have to compete with ... which if positive could dramatically increase the drug's potential. BMS also has high expectations for Zeposia, saying it think sales ...

Another potential rival – Arena Pharma’s oral S1P etrasimod – is in late-stage ... which picked up an FDA approval for this indication last month to add to its current use in rheumatoid ...

The new drug application has also been officially accepted in mainland China and Hong Kong, and etrasimod has officially been approved for adult patients with moderately to severely active UC by the ...

Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal ...

With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...

The approval is only for the 2.5mg tablet. The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with ...

Doron Therapeutics, a clinical-stage biotechnology company based in Chapel Hill, has received a Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration ...

Encelto, the first FDA-approved treatment for MacTel, is implanted intravitreally during a surgery performed by a qualified ophthalmologist. The Food and Drug Administration (FDA) has approved ...

A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. Fellow Japanese drugmaker Ono Pharmaceutical has won an FDA green light for vimseltinib to treat ...

The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults and children. The drug, developed by SpringWorks Therapeutics ...

The FDA is expected to decide on treatments for ... The Company is seeking approval for acute treatment of migraine with or without aura.